An Randomized, Double-blinded Trial of Recombinant Hepatitis E Vaccine (Escherichia Coli) Hecolin to Evaluate Lot-to-lot Consistency
Latest Information Update: 08 May 2020
Price :
$35 *
At a glance
- Drugs Recombinant hepatitis E vaccine (Hecolin) (Primary)
- Indications Hepatitis E
- Focus Pharmacodynamics
- Acronyms the Lot Consistency Trial
- Sponsors Xiamen Innovax Biotech
- 06 May 2020 Status changed from suspended to completed.
- 29 Apr 2020 Planned End Date changed from 1 Jul 2018 to 1 Jun 2020.
- 29 Apr 2020 Status changed from withdrawn prior to enrolment to suspended.